Phase two trial to begin; vaccine by end of year?
When The Tribune first reported in the March 23 Tribune about a vaccine for the novel coronavirus that may be available by this time next year, not many people had heard of the small biotech company that appeared to be first in line to develop the vaccine.
Not many thought it would be possible either.